Rhonda Farnum Theravance Biopharma, Inc. (TBPH) insider trading activity

Rhonda Farnum is SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc.. Currently has a direct ownership of 326,743 shares of TBPH, which is worth approximately $2.69 Million. The most recent transaction as insider was on Aug 20, 2024, when has been sold 9,222 shares (Ordinary Shares) at a price of $8.22 per share, resulting in proceeds of $75,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K

2.74% 3M change

4.06% 12M change

Total Value Held $2.69 Million

Rhonda Farnum Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2024	SELL Payment of exercise price or tax liability	$75,804 $8.22 p/Share	9,222 Reduced 2.74%	326,743 Ordinary Shares
Jul 10 2024	SELL Open market or private sale	$36,000 $9.0 p/Share	4,000 Reduced 1.18%	335,965 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$84,338 $9.1 p/Share	9,268 Reduced 2.65%	339,965 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	37,500 Added 9.7%	349,233 Ordinary Shares
Feb 22 2024	SELL Open market or private sale	$10,922 $8.71 p/Share	1,254 Reduced 0.4%	311,733 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$162,513 $8.92 p/Share	18,219 Reduced 5.5%	312,987 Ordinary Shares
Nov 21 2023	SELL Open market or private sale	$14,179 $10.29 p/Share	1,378 Reduced 0.41%	331,206 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$82,773 $10.37 p/Share	7,982 Reduced 2.34%	332,584 Ordinary Shares
Aug 22 2023	SELL Open market or private sale	$17,112 $9.47 p/Share	1,807 Reduced 0.53%	340,566 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$101,461 $9.7 p/Share	10,460 Reduced 2.96%	342,373 Ordinary Shares
Jun 08 2023	SELL Open market or private sale	$19,922 $11.13 p/Share	1,790 Reduced 0.5%	352,833 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$62,406 $11.21 p/Share	5,567 Reduced 1.55%	354,623 Ordinary Shares
Mar 09 2023	SELL Open market or private sale	$40,800 $10.2 p/Share	4,000 Reduced 1.1%	360,190 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	75,000 Added 17.08%	364,190 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$74,322 $10.44 p/Share	7,119 Reduced 2.4%	289,190 Ordinary Shares
Nov 20 2022	SELL Payment of exercise price or tax liability	$252,457 $10.85 p/Share	23,268 Reduced 7.28%	296,309 Ordinary Shares
Aug 19 2022	SELL Payment of exercise price or tax liability	$97,257 $9.34 p/Share	10,413 Reduced 3.16%	319,577 Ordinary Shares
May 23 2022	SELL Open market or private sale	$9,653 $8.93 p/Share	1,081 Reduced 0.33%	329,990 Ordinary Shares
May 20 2022	SELL Payment of exercise price or tax liability	$19,228 $8.74 p/Share	2,200 Reduced 0.66%	331,071 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$23,937 $10.16 p/Share	2,356 Reduced 0.7%	333,271 Ordinary Shares
Feb 18 2022	SELL Payment of exercise price or tax liability	$113,629 $9.61 p/Share	11,824 Reduced 3.4%	335,627 Ordinary Shares
Dec 14 2021	BUY Grant, award, or other acquisition	-	27,500 Added 7.33%	347,451 Ordinary Shares

Rhonda Farnum

SVP, COMM & MEDICAL AFFAIRS

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account